newswire.com
/1 month ago
Latest updates for Igc
Fresh curated links around IGC are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts
- ICG adds two managing directors to oversee Americas
- IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
alternativecreditinvestor.com
/3 weeks ago
ICG adds two managing directors to oversee Americas
Global alternative asset manager ICG has appointed two managing directors to focus on the Americas. The business has hired Brant Gresham as managing director, head of US West, wher...
newswire.com
/1 week ago
IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment
- Continued Advancement of CALMA Phase 2 Trial -
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Igc
newswire.com
Recent coverage from public sources
Public source
p2pfinancenews.co.uk
Recent coverage from public sources
Public source